HOME >> MEDICINE >> NEWS
Unique laboratory could make pavements more user-friendly

A laboratory specifically designed to make pedestrian environments safer and easier to use is up and running at University College London. This new experimental facility and its potential to enhance quality of life will be described at this year's BA Festival of Science in Norwich.

Research undertaken using PAMELA (Pedestrian Accessibility & Movement Environment Laboratory) is expected to have a positive impact on the lives of all users which is particularly significant in view of the passing of the Disability Discrimination Act in April 2005.

The laboratory makes it possible, for the first time, to observe and understand how all the different factors at work in pedestrian environments can cause difficulties for people using them. By providing detailed insights into how pedestrians are affected by uneven surfaces and visual distractions, for instance, PAMELA will generate data that leads to improvements in the design of pavements, footways and concourses, and will enable new ideas and products to be tried out.

Nick Tyler, Chadwick Professor of Civil Engineering at University College London, has led the development of PAMELA, supported by funding from the Engineering and Physical Sciences Research Council. He will outline the laboratory's capabilities at the BA Festival on 8th September.

PAMELA consists of three key elements, which enable different, realistic combinations of conditions and their impact on people to be studied in a closely controlled scientific environment:

  • An 80m2 computer-controlled platform which can be altered to mimic the characteristics of different pedestrian environments, such as surface material, colour and texture, gradients, steps and obstacles.
  • A lighting system that can mimic different daytime/night-time light conditions.
  • A sound system that can create realistic ambient noise such as traffic movement, railway announcements etc.

A
'"/>

Contact: Natasha Richardson
natasha.richardson@epsrc.ac.uk
44-179-344-4404
Engineering and Physical Sciences Research Council
8-Sep-2006


Page: 1 2

Related medicine news :

1. Unique results from Swedish study of HIV vaccine
2. No butts about it: Unique UH database shows Texas is crushing out smoking
3. Unique vascular dysfunction in womens heart disease described in major journal supplement
4. Taking animals out of laboratory research
5. Wake Forest physician reports first human recipients of laboratory-grown organs
6. Melanoma vaccine strategy shows promise in laboratory experiments
7. Air pollution, high-fat diet cause atherosclerosis in laboratory mice
8. Artificial light at night stimulates breast cancer growth in laboratory mice
9. Seat belt injuries could signal more serious trauma in children
10. Using MRI for diagnosis could help prevent breast cancer progression
11. Metabolic study in mice could lead to good cholesterol boosters

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Unique laboratory could make pavements more user friendly

(Date:7/22/2014)... A Florida woman has filed a ... the death of her husband was the result of ... Liebhard LLP reports. According to her complaint, which was ... Southern District of Florida on June 23rd, the decedent ... subdural hemorrhage the following June. Despite emergency treatment, his ...
(Date:7/22/2014)... 22, 2014) The American Society of Hematology ... University of California Los Angeles with the 2014 ... iron homeostasis, including the discovery of the iron-regulatory hormone ... This award, named after the Nobel Prize Laureate and ... research achievements in hematology that have represented a paradigm ...
(Date:7/22/2014)... you,re a member of the Clean Plate Club you ... you,re not alone! A new Cornell University study shows ... she puts on his or her plate. "If ... stomach," says Brian Wansink Ph.D., author of the forthcoming book, ... Cornell Food and Brand Lab. , Wansink and co-author Katherine ...
(Date:7/22/2014)... 2014) -- The American Society of Hematology (ASH) will ... Coulter Award for Lifetime Achievement in Hematology, to Kanti ... Jewish (LIJ) School of Medicine for his 50-year career ... and mentoring, and exceptional patient care. , The ... is bestowed on an individual who has been a ...
(Date:7/22/2014)... July 22, 2014 SIMpalm, ... updated payment app for Forte Payment System. Forte Mobile ... ACH payments on iPhone, iPod and iPad. The ... been recently updated by SIMpalm. This update was for ... currently supported on iOS 4.3 and is available to ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
(Date:7/22/2014)... 22, 2014 BiologicTx ® today announced ... 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s proprietary ... July 9 at the Miami Transplant Institute, located at ... Kidney Paired Donation (KPD) is ... for kidney transplant with one another due to incompatible ...
(Date:7/22/2014)...  A central New York ... Total Artificial Heart implant is home, discharged from ... Freedom® portable driver to wait for a matching ... from a Syracuse architectural hardware company, suffered from ... medications, an implantable defibrillator and a pacemaker. ...
(Date:7/22/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today ... patients in its ongoing Phase 2 trial (Study 202) ... revised clinical protocol agreed to with the FDA in ... proprietary recombinant human hyaluronidase under development for the systemic ... "Our diligent effort to rapidly re-initiate patient enrollment and ...
Breaking Medicine Technology:BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3
Cached News: